Pfizer and Cipla have reached a price-cut agreement, brokered by the American Cancer Society, to dramatically reduce prices for 16 common chemotherapy drugs in six African countries. As part of the initiative, IBM will simplify treatment guidelines through its Watson supercomputing program.